As countries scramble to secure COVID-19 vaccines, ugly expressions like “vaccine race” and “vaccine nationalism” have entered the global lexicon. But, at a time when global cooperation in sharing vaccines is minimal, and the World Health Organization’s vaccine-distribution plans are yet to get off the ground, India has taken a different tack, quietly pursuing “vaccine diplomacy.”
Its “Vaccine Maitri” (Vaccine Friendship) campaign has shipped hundreds of thousands of Indian-made Covishield vaccines, manufactured under license from Oxford-AstraZeneca, to some 60 countries.
India is a global pharmaceutical powerhouse, manufacturing some 20% of all generic medicines and accounting for as much as 62% of global vaccine production, so it was quick off the mark when the pandemic struck. Before COVID-19 vaccines were developed, India supplied some 100 countries with hydroxychloroquine and paracetamol, and sent pharmaceuticals, test kits, and other equipment to around 90 countries.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.